Marico's Q1 FY26 results resurface: revenue rose 23%, profit up 8%; stake in Plix maker lifted to 60% (August update)
Resurfacing an August 2025 update: Marico reported Q1 FY26 consolidated revenue of Rs 3,259 crore, led by 27% growth in India. Net profit rose 8.2% to Rs 513 crore. The FMCG company also increased its fully diluted stake in Plix maker Satiya Nutraceuticals to 60%, expanding its health and wellness portfolio.
What happened
Marico reported Q1 FY26 profit growth of 8.2% and revenue growth of 23%, led by a 27% rise in India revenue. It increased its fully diluted stake in Plix maker
Key facts
- Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY from Rs 474 crore
- Revenue from operations: Rs 3,259 crore, up 23.31% YoY from Rs 2,643 crore
- Total income: Rs 3,315 crore
- Other income: Rs 56 crore
- India revenue: Rs 2,495 crore, up 27.17% YoY from Rs 1,962 crore
- International revenue: Rs 764 crore, up 12.91% YoY from Rs 681 crore
- India profit before tax: Rs 469 crore
- International profit before tax: Rs 213 crore
- Total expenses: Rs 2,659 crore, up from Rs 2,075 crore
- Marico stake in Satiya Nutraceuticals: 60% fully diluted
Why this matters
Increasing its fully diluted stake in Satiya Nutraceuticals to 60% gives Marico greater control over the Plix platform and accelerates its health-and-wellness portfolio expansion.
What to watch
- India volume growth versus price-led growth in the next two quarters.
- Operating-margin trend and whether profit growth catches up with revenue growth.
- Copra, edible-oil, crude-derivative and packaging-cost movements.
- Advertising and sales-promotion spend as a percentage of revenue.
- Plix revenue growth, distribution expansion, repeat purchases and profitability after Marico takes a 60% stake.
- Rural demand, urban discretionary spending and competitive intensity in foods, nutrition and personal care.
- Any additional capital allocation toward wellness acquisitions or buyout of remaining Plix stake.
- Increase Plix distribution reach through Marico's general-trade, modern-trade and e-commerce network while retaining its digital-native positioning.
- Step up health, nutrition and preventive-wellness product launches, potentially using Plix as a platform for adjacent categories.
- Sustain advertising and promotional spending behind core India brands to defend growth and market share.
- Pursue further minority-stake increases, partnerships or acquisitions in premium wellness and personal-care adjacencies.
- Focus investor communication on volume growth, gross-margin trajectory, advertising intensity and the path to profitability for acquired wellness brands.